Review
Activin signaling as an emerging target for therapeutic interventions
-
* Corresponding author: Kunihiro Tsuchida tsuchida@fujita-hu.ac.jp
1 Division for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake, Aichi 470-1192, Japan
2 Division of Neurology, Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan
3 Mitsubishi Kagaku Institute of Life Sciences, MITILS, 11 Minamiooya, Machida, Tokyo 194-8511, Japan
4 Japan Science and Technology Agency, CREST, Kawaguchi, Saitama 332-0012, Japan
Cell Communication and Signaling 2009, 7:15 doi:10.1186/1478-811X-7-15
Published: 18 June 2009Additional files
Additional file 1:
Table S1. Ligand/receptor combination for activin and related factors. The table provided represents the ligand/receptor combination for activins, inhibins, myostatin, GDF11 and nodal.
Format: PDF Size: 30KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 2:
Table S2. Activin signaling as a target for therapeutic interventions. The table provided represents activin signaling as a target for therapeutic interventions and lists the disease, therapeutic strategy, methods and references.
Format: PDF Size: 62KB Download file
This file can be viewed with: Adobe Acrobat Reader